Shimkin et al., 1958 - Google Patents
Adjuvant use of chemotherapy in the surgical treatment of cancer: plan of cooperative studyShimkin et al., 1958
- Document ID
- 5944365790441370164
- Author
- Shimkin M
- Moore G
- Publication year
- Publication venue
- Journal of the American Medical Association
External Links
Snippet
A plan is described for the cooperation of 48 departments of surgery under the auspices of the National Cancer Institute in a study of the effectiveness of chemotherapy as an adjuvant to the surgical treatment of cancer. It has three aims: to improve the prognosis of the patient …
- 201000011510 cancer 0 title abstract description 45
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shimkin et al. | Adjuvant use of chemotherapy in the surgical treatment of cancer: plan of cooperative study | |
| Byar et al. | Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer | |
| Krikorian et al. | Malignant neoplasms following cardiac transplantation | |
| Paryani et al. | Analysis of non‐Hodgkin's lymphomas with nodular and favorable histologies, stages I and II | |
| Abulafi et al. | Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy | |
| Bell et al. | Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study | |
| Feun et al. | The natural history of resectable metastatic melanoma (stage IVA melanoma) | |
| Murphy | Management of Childhood Non-Hodgkin's Lymphoma¹ | |
| Woolley III et al. | Extranodal presentation of non‐Hodgkin's lymphomas in the testis | |
| Favret et al. | Locally advanced breast cancer: is surgery necessary? | |
| Krag et al. | Predictive factors for long-term survival in patients with advanced ovarian cancer | |
| Sposto et al. | Comparison of long‐term outcome of children and adolescents with disseminated non‐lymphoblastic non‐Hodgkin lymphoma treated with COMP or daunomycin‐COMP: A report from the Children's Cancer Group | |
| Kenady et al. | Effect of thymosin in vitro on T cell levels during radiation therapy. Correlations with radiation portal and initial T cell levels | |
| Nielsen et al. | Orgotein in radiation treatment of bladder cancer: a report on allergic reactions and lack of radioprotective effect | |
| Higgins et al. | Efficacy of MER immunotherapy when added to a regimen of 5‐fluorouracil and methyl‐CCNU following resection for carcinoma of the large bowel. A veterans administration surgical oncology group report | |
| Nichols | Treatment of recurrent germ cell tumors | |
| Falkson, G., Falkson, HC & Fichardt | Combined telecobalt and 5-fluorouracil therapy in carcinoma of the pancreas: A report of 97 cases | |
| Kydd et al. | A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART)–design and rationale | |
| Wiseman et al. | Clinical responses with active specific intralymphatic immunotherapy for cancer--a phase I-II trial | |
| Robinson et al. | The combination of surgery, radiotherapy, and chemotherapy in the treatment of gastric cancer | |
| Rosen et al. | Sequential multi-agent chemotherapy and whole abdominalirradiation for stage III ovarian carcinoma | |
| Doodnauth et al. | Case Report A Rare Presentation of Checkpoint Inhibitor Induced Distal RTA | |
| Miller et al. | Assessment of syngeneic cell-mediated immunity to mouse mammary tumors by three different assays: Correlation with in vivo tumor behavior | |
| US20020031473A1 (en) | In vivo chemosensitivity screen for human tumors | |
| Marvin Pollard et al. | Staging of cancer of the pancreas |